OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
September 30, 2026 — OS Therapies reports 75% 2-year survival in osteosarcoma trial, plans regulatory filings for OST-HER2 with FDA and UK MHRA by year-end 2025.
Curated Business Corporate News
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
September 30, 2026 — OS Therapies advances OST-HER2 immunotherapy for osteosarcoma with FDA RMAT designation. Phase 2b results show significant survival improvement. Potential 2026 launch with commercial partner Eversana.
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
May 31, 2026 — Cingulate advances CTx-1301 ADHD treatment with FDA acceptance and 2026 PDUFA date. Stonegate updates coverage as company prepares for potential commercial launch.
Georgia Launches Think Tank to Combat Maternal Mortality Crisis
January 29, 2026 — Georgia launches Maternal Health Vitality Think Tank to address high maternal mortality rates. This coalition unites healthcare, community & research leaders for systemic change.
Peapack-Gladstone Reports Strong Q4 2025 Results with 26% Income Growth
January 29, 2026 — Peapack-Gladstone Financial reports Q4 2025 net income of $12.2M, up 26% from previous quarter. Deposits grew to $6.6B with strong NIM expansion to 3.08%.
Soligenix Advances Novel Light Therapy for Hard-to-Diagnose Skin Cancer
January 29, 2026 — Soligenix develops HyBryte™, a novel visible light therapy for early-stage cutaneous T-cell lymphoma (CTCL) that targets cancer cells while minimizing damage to healthy tissue.
Soligenix Advances Novel Light Therapy for Hard-to-Diagnose Skin Cancer
January 29, 2026 — Soligenix develops HyBryte, a visible light therapy for early-stage cutaneous T-cell lymphoma (CTCL), offering a safer alternative to UV treatments with proven efficacy in clinical trials.
Soligenix Advances Novel Light Therapy for Hard-to-Diagnose Skin Cancer
January 29, 2026 — Soligenix develops HyBryte™, a visible light therapy for early-stage cutaneous T-cell lymphoma (CTCL), offering safer treatment with significant clinical efficacy.
Soligenix Advances Novel CTCL Therapy with Visible Light Treatment
January 29, 2026 — Soligenix develops HyBryte™, a visible light-activated therapy for early-stage cutaneous T-cell lymphoma (CTCL), showing significant efficacy in clinical trials while minimizing safety risks.
Trilogy Metals Bolsters Teams, Unveils 2026 Budget After Federal Investment
January 29, 2026 — Trilogy Metals strengthens leadership, releases 2026 budget for Alaska critical minerals projects after securing federal investment. Details on Ambler Metals joint venture.
Powermax Minerals Completes Key 2025 REE Exploration Program in Ontario
January 29, 2026 — Powermax Minerals completes 2025 REE exploration at Atikokan property in Ontario, advancing critical minerals portfolio with geological mapping and sampling across multiple lithological domains.
GlobalTech Acquires U.K. Footwear Brand MIP to Deploy AI Platform
January 29, 2026 — GlobalTech acquires 51% of U.K. footwear brand Moda in Pelle to deploy its Thrivo AI platform, expanding ecommerce capabilities and market presence in a strategic tech-retail fusion.
BioVaxys' Cancer Immunotherapy Shows Promise in Overcoming Treatment Resistance
January 29, 2026 — BioVaxys reports positive Phase 2 results for MVP-S immunotherapy in metastatic bladder cancer, showing complete responses in checkpoint-refractory patients and potential to overcome treatment resistance.
Search Minerals Advances Critical Rare Earth Projects with Innovative Leadership
January 29, 2026 — Search Minerals Inc. advances critical rare earth projects in Newfoundland with innovative extraction tech and experienced leadership, targeting efficiency and sustainability in mining.
LaFleur Minerals Advances Gold Mill Recommissioning Amid Record Prices
January 29, 2026 — LaFleur Minerals advances Beacon Gold Mill recommissioning in Quebec's Abitibi gold belt amid record gold prices. The mill supports Swanson Gold Deposit and offers custom processing for major miners.
Rail Vision Acquires Quantum Tech to Revolutionize Railway Safety
January 29, 2026 — Rail Vision completes acquisition of Quantum Transportation, integrating quantum error correction tech with AI railway safety systems to address global rail challenges.
Earth Science Tech's 47% Insider Ownership Aligns Management with Investors
January 29, 2026 — Earth Science Tech's management owns 47% of shares, aligning interests with investors. Learn about this OTC company's unique ownership structure and financial alignment.
McEwen Inc. to Acquire Golden Lake Exploration in Strategic Nevada Mining Deal
January 29, 2026 — McEwen Inc. announces acquisition of Golden Lake Exploration, adding Nevada's Jewel Ridge projects to its portfolio at a 60% premium, targeting completion in March 2026.
Provident Financial Services Reports Record Revenue and Profit in Q4 2025
January 29, 2026 — Provident Financial Services reports record Q4 2025 revenue of $225.7M and net income of $83.4M, with EPS of $0.64 and ROAA of 1.34%, showcasing strong profitability.
ADM Endeavors' Just Right Products Powers Unspeakable's Winter Merch Drop
January 29, 2026 — ADM Endeavors' Just Right Products produces winter merchandise for YouTube star Unspeakable, including hoodies and headwear with bagging and barcode services for direct-to-fan fulfillment.